Lycia Therapeutics LYCA

Lycia Therapeutics files for IPO

Securities offering

Form
S-1
Filed
Importance
Notable
  1. Offers common stock for initial public offering
  2. Plans to list on Nasdaq under LYCA
  3. Underwriters include Jefferies, TD Cowen, Evercore ISI, Guggenheim Securities

Written from the S-1 on EDGAR. Check the filing before you rely on it.

Get an email when Lycia Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float not reported.